CD163 and gastric cancer: For example, the heterogeneity and distribution of TAMs in breast and gastric cancers were explored through fluorescence microimaging and a multiplex panel including markers like CD68, CD163, CD206, IRF8, and PDL1, identifying distinct TAM populations within tumor and adjacent tissues [22, 24].